{"schema_version":"secwatch.filing_event.v1","accession":"0001824293-26-000030","form_type":"8-K","ticker":"GRI","cik":"0001824293","company_name":"GRI Bio, Inc.","filed_at":"2026-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.370602+00:00","generated_at":"2026-05-16T06:03:40.957727+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"GRI Bio expands ATM equity offering capacity from $10M to $60M via H.C. Wainwright amendment","bullets":["Amendment to At The Market Offering Agreement increases aggregate offering price to $60 million.","Prior cap was $10 million; amended agreement effective January 28, 2026.","Waivers obtained from December 2025 Securities Purchase Agreement investor to permit ATM issuances.","Prospectus supplement filed Jan 29, 2026 to register up to $60M of common stock.","Sales agent remains H.C. Wainwright & Co., LLC; shares sold at market prices."],"urls":{"canonical":"https://secwatch.observer/filing/0001824293-26-000030","json":"https://secwatch.observer/filing/0001824293-26-000030.json","markdown":"https://secwatch.observer/filing/0001824293-26-000030.md","text":"https://secwatch.observer/filing/0001824293-26-000030.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1824293/000182429326000030/0001824293-26-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1824293/000182429326000030/val-20260129.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T06:03:40.957727+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d2f87eae0cad4a2fc35cf88fc3b71a0d95d80d66","claim":"GRI Bio, Inc. amended Amendment No. 1 to At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at increase the aggregate offering price of the Shares that the Company may sell in the ATM Offering fr (effective 2026-01-28).","evidence_excerpt":"On January 29, 2026, the Company entered into an Amendment No. 1 to At The Market Offering Agreement (the “Amendment”) with Wainwright, effective as of January 28, 2026, to increase the aggregate offering price of the Shares that the Company may sell in the ATM Offering from $10,000,000 to up to the dollar amount of Shares registered on the prospectus supplement pursuant to which the ATM Offering is being made.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1824293/000182429326000030/0001824293-26-000030-index.htm","confidence":0.98,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Value","value":"increase the aggregate offering price of the Shares that the Company may sell in the ATM Offering fr"},{"label":"Effective","value":"2026-01-28"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}